Ongoing Clinical Trials Ongoing Clinical Trials

Ongoing Clinical Trials

Home >> Clinical Trial Guidance >> Ongoing Clinical Trials

We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.

* Protocol No. KM-10(B)
* Research Title Open label, multicenter, prospective phase II study to investigate the efficacy and safety of Trastuzumab biosimilar plus treatment of physician’s choice in Patients with HER-2 Positive Metastatic Breast Cancer Who Progressed after 2 or more HER-2 ...
* Overall Research Director Park In-Hye Affiliate National Cancer Center
Carcinoma Metastatic breast cancer
Target Gene HER2 Clinical Trial Drug Trastuzumab+ Selected anti-cancer drugs
Research period 2018.12.01 ~ 2021.12.31 Progress Status registering
Number of recipients 21 / 119 Registration rate 17.65%

Institutional research participation

No. Research manager Research institution

:: There is no registered research participant information. ::

prev list next

arrow Method of participation

If you want to participate in the clinical examination, please contact the email address below.

Email | CONTACT Secretariat 02.2286.1564 | Clinical Trial Coordinating Center 02.2286.1562